Mats Wahlgren Selected Research

Mats Wahlgren Research Topics

Disease

58	Malaria 01/2021 - 07/2004
16	Infections 01/2020 - 09/2006
9	Falciparum Malaria (Plasmodium falciparum Malaria) 11/2021 - 04/2008
4	Acute malaria 08/2011 - 04/2006
3	Inflammation (Inflammations) 01/2019 - 04/2013
3	Persistent Infection 10/2017 - 11/2007
3	Type I Syndactyly 01/2015 - 03/2008
2	Cerebral Malaria 04/2020 - 04/2014
2	Parasitemia 01/2019 - 08/2013
1	COVID-19 11/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Convalescence 04/2020
1	Anemia 12/2018
1	Disease Progression 12/2018
1	Hemolysis 12/2018
1	Rupture 01/2018
1	Hemorrhage 01/2017
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2017
1	AIDS-Related Complex (ARC) 02/2016
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 08/2011
1	Lymphoma (Lymphomas) 08/2011

Drug/Important Bio-Agent (IBA)

17	AntibodiesIBA 01/2018 - 07/2004
14	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2008
14	AntigensIBA 01/2018 - 08/2004
13	VaccinesIBA 01/2019 - 07/2004
7	ABO Blood-Group SystemIBA 11/2021 - 01/2015
6	Blood Group Antigens (Blood Groups)IBA 03/2020 - 01/2015
5	Surface Antigens (Surface Antigen)IBA 10/2017 - 02/2010
5	Heparin (Liquaemin)FDA LinkGeneric 01/2017 - 09/2006
5	Immunoglobulin G (IgG)IBA 01/2015 - 04/2007
4	sevuparinIBA 01/2019 - 03/2011
3	Peptides (Polypeptides)IBA 08/2017 - 01/2013
3	GlycosaminoglycansIBA 05/2013 - 09/2006
2	Antimalarials (Antimalarial Agents)IBA 01/2019 - 01/2011
2	Heparitin Sulfate (Heparan Sulfate)IBA 01/2017 - 09/2006
2	LigandsIBA 01/2017 - 05/2013
2	Immunoglobulin M (IgM)IBA 02/2016 - 08/2013
2	Plasmodium falciparum erythrocyte membrane protein 1IBA 01/2015 - 01/2014
2	Merozoite Surface Protein 1 (MSA1)IBA 08/2013 - 04/2013
2	AutoantibodiesIBA 08/2011 - 09/2006
2	polyclonal B cell activatorIBA 12/2009 - 09/2006
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	ClusterinIBA 04/2020
1	AnticoagulantsIBA 01/2019
1	Heparinoids (Heparinoid)IBA 01/2019
1	HaptoglobinsIBA 12/2018
1	ThioredoxinsIBA 01/2018
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 05/2017
1	proguanil drug combination atovaquone (malarone)FDA Link 01/2017
1	artemisinin (artemisinine)IBA 11/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2015
1	Basic Amino Acids (Basic Amino Acid)IBA 01/2015
1	SuspensionsIBA 04/2014
1	Glucose (Dextrose)FDA LinkGeneric 04/2014
1	Muscle Proteins (Muscle Protein)IBA 04/2014
1	EnzymesIBA 08/2013
1	Carrier Proteins (Binding Protein)IBA 08/2013
1	ImmunosorbentsIBA 08/2013
1	HMGB1 Protein (HMG1)IBA 04/2013
1	CytokinesIBA 04/2013
1	Codon (Codons)IBA 03/2013
1	Chloroquine (Aralen)FDA LinkGeneric 03/2013
1	pyrimethamine drug combination fanasil (Fansidar)FDA Link 09/2012
1	Quinine (Quinson)FDA Link 12/2010
1	mannide monooleateIBA 07/2010
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2009
1	Complement Factor D (Factor D)IBA 04/2007
1	AlbuminsIBA 04/2007
1	Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA 04/2007
1	DNA (Deoxyribonucleic Acid)IBA 04/2006
1	Complement System Proteins (Complement)IBA 11/2005
1	EpitopesIBA 06/2005
1	Polysaccharides (Glycans)IBA 08/2004

Therapy/Procedure

5	Therapeutics 01/2017 - 11/2005
1	Glycemic Control 01/2021
1	Blood Transfusion (Blood Transfusions) 12/2018
1	Intravenous Infusions 01/2017
1	Aftercare (After-Treatment) 01/2011